On September 4, 2024, E Corcoran, Director at Phibro Animal Health Corp (PAHC, Financial), purchased 5,000 shares of the company, as reported in a recent SEC Filing. This transaction increased the insider's holdings to 25,000 shares.
Phibro Animal Health Corp is engaged in the development, manufacture, and marketing of a broad range of animal health and mineral nutrition products. The company's products help manage food supply by improving the health and productivity of livestock and poultry.
The shares were acquired at a price of $20.02 per share, valuing the transaction at $100,100. Following this purchase, the total value of shares held by the insider in the company is approximately $500,500.
The insider transaction history for Phibro Animal Health Corp shows a trend of more buying than selling among insiders over the past year, with this purchase being one of the notable buys. Over the past year, E Corcoran has purchased a total of 5,000 shares and has not sold any shares.
Shares of Phibro Animal Health Corp were trading at $20.02 on the day of the transaction. The company has a market cap of approximately $788.2 million. The price-earnings ratio stands at 324.33, significantly above both the industry median and the company's historical median.
According to the GF Value, the intrinsic value estimate for Phibro Animal Health Corp is $16.57 per share, making the stock modestly overvalued with a price-to-GF-Value ratio of 1.21.
This insider buy might signal a positive outlook from the insider on the company's future performance, despite the current valuation metrics suggesting a premium over the intrinsic value as estimated by GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
